Microglia-mediated neuroinflammation is one of the most significant features in a variety of
central nervous system (CNS) disorders such as traumatic brain injury, stroke, and many …

Microglia-mediated neuroinflammation is a common feature of neurodegenerative diseases
such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis …

Neuroinflammation regulated by microglia is one of the important factors involved in the
pathogenesis of Alzheimer's disease (AD). Activated microglia exhibited phenotypes termed …

Alzheimer's disease (AD) is the most prevalent neurodegenerative disease that results in
progressive dementia, and exhibits high disability and fatality rates. Recent evidence has …

abstract Neurodegenerative diseases (NDs) are characterized by the progressive loss of
structure and function of neurons most common in elderly population, mainly including …

Neuroinflammation, an inflammatory response within the central nervous system (CNS), is a
main hallmark of common neurodegenerative diseases, including Alzheimer's disease (AD) …

Given the emergence of nanotherapeutics and nanodiagnostics as key tools in today's
medicine, it has become of critical importance to define precisely the interactions of …

The blood–brain barrier (BBB) is a protective endothelial barrier lining the brain
microvasculature which prevents brain delivery of therapies against brain diseases. Hence …

Microglia are resident macrophage-like immune cells in the central nervous system (CNS)
and play a vital role in both physiological and pathological conditions, including restoring …

Drug discovery for Parkinson's disease (PD) is challenging. Here we report that gold
nanoclusters (AuNCs) can serve as a novel candidate for the design of anti-PD drugs. With …